Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Arhaus, Inc. (ARHS) has a Wall Street consensus price target of $10.75, based on estimates from 14 covering analysts. With the stock currently trading at $8.25, this represents a potential upside of +30.3%. The company has a market capitalization of $719M.
Analyst price targets range from a low of $9.50 to a high of $12.00, representing a 23% spread in expectations. The median target of $10.75 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ARHS trades at a trailing P/E of 17.2x and forward P/E of 16.2x. The forward PEG ratio of 0.54 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +7.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $10.74, with bear and bull scenarios of $4.82 and $37.30 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ARHS stacks up against sector leader Alibaba Group Holding Limited.
Start ComparisonThe consensus Wall Street price target for ARHS is $10.75, representing 30.3% upside from the current price of $8.25. With 14 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARHS has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $10.75 implies 30.3% upside from current levels.
With a forward P/E of 16.2051x, ARHS trades at a relatively low valuation. The consensus target of $10.75 implies 30.3% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $12 for ARHS, while the most conservative target is $9.5. The consensus of $10.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $37 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ARHS is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARHS stock forecast based on 14 Wall Street analysts shows a consensus price target of $10.75, with estimates ranging from $9.5 (bear case) to $12 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $11, with bear/bull scenarios of $5/$37.
Our quantitative valuation model calculates ARHS's fair value at $11 (base case), with a bear case of $5 and bull case of $37. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
ARHS trades at a forward P/E ratio of 16.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ARHS, with a "Buy" consensus rating and $10.75 price target (30.3% upside). 7 of 14 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARHS analyst price targets range from $9.5 to $12, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10.75 consensus represents the middle ground. Our model's $5-$37 range provides an independent fundamental perspective.